Literature DB >> 16284693

Predictors of local failure in early laryngeal cancer.

R Lohynska1, A Slavicek, A Bahanan, P Novakova.   

Abstract

The aim of the study was to assess the impact of factors that could predict the probability of local failure in early laryngeal squamous cell carcinoma treated with curative radiotherapy. Sixty seven patients (12 women and 55 men) with laryngeal cancer stage I (47 patients) and stage II (20 patients) were treated from 1998 to 2003 with curative radiotherapy and retrospectively evaluated. Median follow-up was 36 months (3-80). Local relapse occurred in 10 patients (15%), regional lymphnodes relapse affected 2 patients. The median time between start of radiotherapy to recurrence was 13 months (3-48). Death due to cancer occurred in 4 patients (2 died from locoregional progression of the recurrence and 2 from distant metastases), whereas 7 patients died from non-cancer related causes. The 2-year overall survival rate was 90% and 5-year OS was 79%. The 2-year local control rate was 82% and 5-year local control was 79%. In the univariate analysis there was a statistically significant decrease in local control influenced by grading (p < 0.0001). High risk group of relapse encompassed patients with at least two negative factors: supraglottic tumor, women, radiotherapy prolongation by 3 or more days and high grade tumor and has 3 times worse local control than low risk group (p=0.0125). The highest risk of local recurrence was in the first three years after radiotherapy than later (p=0.0057). On multivariate analysis unfavourable prognostic factors for local control were gender (p=0.022), presence of 2 or more negative risk factors (p=0.018) and lengths of follow up (p=0.005). Radiation dose, stage, age, hemoglobin level and anterior commissure involvement were not significant factors for local control. Overall survival was affected both in the univariate and multivariate analysis by presence of local relapse (p < 0.005) and follow up duration (p < 0.02). Anemia had borderline significance for overall survival in univariate analysis (p=0.064), but in the multivariate analysis was significant unfavourable factor (p=0.008). Other studied factors (radiation dose, anterior commissure involvement and age) were not reaching level of statistical significant value for overall survival. Close follow up strategy is recommended for high risk group of patients with two or more risk factors especially in the first three years after radiation therapy.

Entities:  

Mesh:

Year:  2005        PMID: 16284693

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  12 in total

1.  MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.

Authors:  Shuo Wu; Shenshan Jia; Ping Xu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Outcome of conservation surgery for laryngeal carcinoma: an 8-year trial.

Authors:  Bilge Tuna; Hüseyin Katilmiş; Sedat Oztürkcan; Ali Ekber Ilknur; Riza Dündar; Yimaz Ozkul; Sinem Aktaş; Filiz Gülistan
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11       Impact factor: 2.503

Review 3.  Primary treatment of the anterior vocal commissure squamous carcinoma.

Authors:  Patrick J Bradley; Alessandra Rinaldo; Carlos Suárez; Ashok R Shaha; C René Leemans; Johannes A Langendijk; Snehal G Patel; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-15       Impact factor: 2.503

4.  Cancer of the larynx in Puerto Rico.

Authors:  Albert Villanueva-Reyes; Edythe Strand; Cruz María Nazario; Margarita Irizarry-Ramírez
Journal:  P R Health Sci J       Date:  2008-09       Impact factor: 0.705

5.  Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma.

Authors:  Theodoros A Papadas; Evangelos C Alexopoulos; Antony Mallis; Eleni Jelastopulu; Nicholas S Mastronikolis; Panos Goumas
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-18       Impact factor: 2.503

6.  Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients.

Authors:  Tian-Run Liu; Li-Hua Xu; An-Kui Yang; Qian Zhong; Ming Song; Man-Zhi Li; Li-Juan Hu; Fu-Jin Chen; Ze-Dong Hu; Ping Han; Mu-Sheng Zeng
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

7.  The effect of tumor volume on radiotherapy outcome and correlation with other prognostic factors in patients with T2 supraglottic cancer.

Authors:  Tomasz W Rutkowski; Bogusław Maciejewski; Zofia Kołosza; Andrzej Wygoda; Krzysztof Składowski; Beata Hejduk; Roman Rutkowski
Journal:  Contemp Oncol (Pozn)       Date:  2014-12-31

8.  Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Xiao-Ning Luo; Liang-Si Chen; Ping-Jiang Ge; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

9.  Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma.

Authors:  Xue-Kui Liu; Xin-Rui Zhang; Qian Zhong; Man-Zhi Li; Zhi-Min Liu; Zhi-Rui Lin; Di Wu; Mu-Sheng Zeng
Journal:  J Transl Med       Date:  2013-03-07       Impact factor: 5.531

10.  Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients.

Authors:  Siwen Dang; Yiping Qu; Jing Wei; Yuan Shao; Qi Yang; Meiju Ji; Bingyin Shi; Peng Hou
Journal:  Diagn Pathol       Date:  2014-02-05       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.